Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |